Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Premature ovarian failure.

Deepti Goswami1, Gerard S Conway

  • 1Department of Endocrinology, The Middlesex Hospital, London W1T 3AA, UK.

Human Reproduction Update
|May 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Programmed death ligand-1 (PD-L1) expression in serous ovarian carcinoma with clinicopathological associations.

The Indian journal of medical research·2026
Same author

Unexpected Malignancy in Women Undergoing Surgery for Uterine Fibroids.

Cureus·2026
Same author

Complete Androgen Insensitivity Syndrome in a Phenotypic Female: The Role of Frozen Section in Assisting Diagnosis.

Cureus·2025
Same author

Prevalence and predictors of non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) in Indian women with polycystic ovarian syndrome.

The journal of obstetrics and gynaecology research·2025
Same author

Mapping the anatomical and transcriptional landscape of early human fetal ovary development.

Scientific reports·2025
Same author

A Tiered Approach to Exome Sequencing Analysis in Early-Onset Primary Ovarian Insufficiency.

The Journal of clinical endocrinology and metabolism·2025
Same journal

Clinical outcomes and euploidy rates of embryos derived from zygotes with nonpronuclear (0PN) and monopronuclear (1PN) in IVF or ICSI cycles: a systematic review and meta-analysis.

Human reproduction update·2026
Same journal

Sperm mitochondrial DNA copy number: a marker of male fertility and reproductive success.

Human reproduction update·2026
Same journal

Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review.

Human reproduction update·2026
Same journal

Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.

Human reproduction update·2026
Same journal

Maternal genetic variants associated with aneuploid conception: a narrative review.

Human reproduction update·2026
Same journal

Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health.

Human reproduction update·2026
See all related articles

Premature ovarian failure (POF) affects 1% of women, often with unknown causes like genetic factors or autoimmune issues. Diagnosis involves amenorrhea before 40 and high FSH; management focuses on hormone replacement and assisted reproduction.

Area of Science:

  • Reproductive Endocrinology
  • Genetics
  • Immunology

Background:

  • Premature ovarian failure (POF), or hypergonadotropic hypogonadism, affects 1% of women, frequently with unidentified etiologies.
  • Known contributing factors include genetic aberrations, autoimmune ovarian damage, iatrogenic causes (e.g., cancer treatments), and environmental exposures.
  • The specificity and pathogenic role of anti-ovarian antibodies in POF remain uncertain.

Purpose of the Study:

  • To review the known causes, diagnostic approaches, and management strategies for premature ovarian failure.
  • To highlight the current understanding of genetic, autoimmune, iatrogenic, and environmental factors implicated in POF.
  • To discuss the diagnostic criteria and therapeutic options, including hormone replacement and assisted reproductive technologies.

Main Methods:

Related Experiment Videos

  • Review of literature on premature ovarian failure etiology, diagnosis, and management.
  • Analysis of diagnostic criteria including amenorrhea before age 40 and follicle-stimulating hormone (FSH) levels.
  • Evaluation of treatment modalities such as hormone replacement therapy and assisted conception.

Main Results:

  • The majority of POF cases lack identified causes, despite screening for genetic mutations and investigating autoimmune associations.
  • Diagnosis relies on clinical presentation (amenorrhea <40 years) and elevated FSH, with karyotyping recommended for early-onset cases.
  • Ovarian biopsy and ultrasound are not indicated for POF diagnosis.

Conclusions:

  • Effective management of POF primarily involves hormone replacement therapy and assisted conception using donated oocytes for infertility.
  • Ovarian tissue, oocyte, and embryo cryopreservation offer future fertility preservation options for women facing potentially ovarian-damaging treatments.
  • Further research is needed to elucidate the specific genetic and autoimmune mechanisms underlying idiopathic premature ovarian failure.